Abstract
Cells use transcription-coupled nucleotide excision repair (TC-NER) to efficiently resolve transcription-blocking DNA lesions caused by genotoxic stress such as ultraviolet (UV) irradiation. However, UV also induces RNA damage, triggering a cytoplasmic ribotoxic stress response (RSR). Whether and how RSR affects nuclear TC-NER has remained unclear. Here we identify INTS12, a flexible, poorly characterized subunit of the Integrator complex, as a key mediator linking RSR to TC-NER. Specifically, RSR-activated ZAK signaling induces phosphorylation of INTS12, enhancing its interaction with CSB and promoting recruitment of the Integrator complex to lesion-stalled RNA polymerase II (Pol II). This facilitates Pol II clearance and enables efficient DNA repair through TC-NER. Disruption of this pathway compromises TC-NER and transcription recovery, thereby increasing cellular sensitivity to UV-induced damage. Notably, the requirement for INTS12-mediated Pol II removal is context dependent, as it is not advantageous during the transcription-coupled response to formaldehyde-induced DNA–protein crosslinks, which rely on a distinct proteasome-dependent degradation pathway. Together, these findings uncover a regulatory axis connecting RNA damage signaling to DNA repair and highlight a context-dependent role of INTS12 in maintaining genome integrity.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout





Data availability
MS data were deposited to ProteomeXchange (PXD066142). ChIP-seq and RNA-seq data were uploaded to the Genome Sequence Archive of The National Genomics Data Center, the China National Center for Bioinformation/Beijing Institute of Genomics and the Chinese Academy of Sciences (HRA009292). All other data supporting the findings of this study are available from the corresponding author upon reasonable request. Source data are provided with this paper.
References
Huang, R. & Zhou, P. K. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal. Transduct. Target. Ther. 6, 254 (2021).
Jackson, S. P. & Bartek, J. The DNA-damage response in human biology and disease. Nature 461, 1071–1078 (2009).
van den Heuvel, D., van der Weegen, Y., Boer, D. E. C., Ogi, T. & Luijsterburg, M. S. Transcription-coupled DNA repair: from mechanism to human disorder. Trends Cell Biol. 31, 359–371 (2021).
Selby, C. P., Lindsey-Boltz, L. A., Li, W. & Sancar, A. Molecular mechanisms of transcription-coupled repair. Annu. Rev. Biochem. 92, 115–144 (2023).
Nieto Moreno, N., Olthof, A. M. & Svejstrup, J. Q. Transcription-coupled nucleotide excision repair and the transcriptional response to UV-induced DNA damage. Annu. Rev. Biochem. 92, 81–113 (2023).
Mellon, I., Spivak, G. & Hanawalt, P. C. Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell 51, 241–249 (1987).
Bohr, V. A., Smith, C. A., Okumoto, D. S. & Hanawalt, P. C. DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell 40, 359–369 (1985).
Xu, J. et al. Structural basis for the initiation of eukaryotic transcription-coupled DNA repair. Nature 551, 653–657 (2017).
van der Weegen, Y. et al. The cooperative action of CSB, CSA, and UVSSA target TFIIH to DNA damage-stalled RNA polymerase II. Nat. Commun. 11, 2104 (2020).
Kokic, G., Wagner, F. R., Chernev, A., Urlaub, H. & Cramer, P. Structural basis of human transcription–DNA repair coupling. Nature 598, 368–372 (2021).
van den Heuvel, D. et al. STK19 facilitates the clearance of lesion-stalled RNAPII during transcription-coupled DNA repair. Cell 187, 7107–7125 (2024).
Tan, Y. et al. STK19 is a transcription-coupled repair factor that participates in UVSSA ubiquitination and TFIIH loading. Nucleic Acids Res. 52, 12767–12783 (2024).
Ramadhin, A. R. et al. STK19 drives transcription-coupled repair by stimulating repair complex stability, RNA Pol II ubiquitylation, and TFIIH recruitment. Mol. Cell 84, 4740–4757 (2024).
Mevissen, T. E. T., Kummecke, M., Schmid, E. W., Farnung, L. & Walter, J. C. STK19 positions TFIIH for cell-free transcription-coupled DNA repair. Cell 187, 7091–7106 (2024).
Chiou, Y. Y., Hu, J., Sancar, A. & Selby, C. P. RNA polymerase II is released from the DNA template during transcription-coupled repair in mammalian cells. J. Biol. Chem. 293, 2476–2486 (2018).
Tufegdzic Vidakovic, A. et al. Regulation of the RNAPII pool is integral to the DNA damage response. Cell 180, 1245–1261 (2020).
Nakazawa, Y. et al. Ubiquitination of DNA damage-stalled RNAPII promotes transcription-coupled repair. Cell 180, 1228–1244 (2020).
Powley, I. R. et al. Translational reprogramming following UVB irradiation is mediated by DNA-PKcs and allows selective recruitment to the polysomes of mRNAs encoding DNA repair enzymes. Genes Dev. 23, 1207–1220 (2009).
Donahue, B. A., Yin, S., Taylor, J. S., Reines, D. & Hanawalt, P. C. Transcript cleavage by RNA polymerase II arrested by a cyclobutane pyrimidine dimer in the DNA template. Proc. Natl Acad. Sci. USA 91, 8502–8506 (1994).
Hara, R., Selby, C. P., Liu, M., Price, D. H. & Sancar, A. Human transcription release factor 2 dissociates RNA polymerases I and II stalled at a cyclobutane thymine dimer. J. Biol. Chem. 274, 24779–24786 (1999).
Zhu, Y. et al. Coordination of transcription-coupled repair and repair-independent release of lesion-stalled RNA polymerase II. Nat. Commun. 15, 7089 (2024).
Lai, F., Gardini, A., Zhang, A. & Shiekhattar, R. Integrator mediates the biogenesis of enhancer RNAs. Nature 525, 399–403 (2015).
Kirstein, N., Gomes Dos Santos, H., Blumenthal, E. & Shiekhattar, R. The Integrator complex at the crossroad of coding and noncoding RNA. Curr. Opin. Cell Biol. 70, 37–43 (2021).
Xu, C. et al. R-loop-dependent promoter-proximal termination ensures genome stability. Nature 621, 610–619 (2023).
Wagner, E. J., Tong, L. & Adelman, K. Integrator is a global promoter-proximal termination complex. Mol. Cell 83, 416–427 (2023).
Zheng, H. et al. Identification of Integrator–PP2A complex (INTAC), an RNA polymerase II phosphatase. Science 370, eabb5872 (2020).
Elrod, N. D. et al. The Integrator complex attenuates promoter-proximal transcription at protein-coding genes. Mol. Cell 76, 738–752 (2019).
Zheng, H. et al. Structural basis of INTAC-regulated transcription. Protein Cell 14, 698–702 (2023).
Fianu, I. et al. Structural basis of Integrator-dependent RNA polymerase II termination. Nature 629, 219–227 (2024).
Qiu, M. et al. CDK12 and Integrator–PP2A complex modulates LEO1 phosphorylation for processive transcription elongation. Sci. Adv. 9, eadf8698 (2023).
Liu, X. et al. The PAF1 complex promotes 3′ processing of pervasive transcripts. Cell Rep. 38, 110519 (2022).
Rosa-Mercado, N. A. et al. Hyperosmotic stress alters the RNA polymerase II interactome and induces readthrough transcription despite widespread transcriptional repression. Mol. Cell 81, 502–513 (2021).
Dasilva, L. F. et al. Integrator enforces the fidelity of transcriptional termination at protein-coding genes. Sci. Adv. 7, eabe3393 (2021).
Fianu, I. et al. Structural basis of Integrator-mediated transcription regulation. Science 374, 883–887 (2021).
Pfleiderer, M. M. & Galej, W. P. Structure of the catalytic core of the Integrator complex. Mol. Cell 81, 1246–1259 (2021).
Zhao, S. et al. RNF14-dependent atypical ubiquitylation promotes translation-coupled resolution of RNA-protein crosslinks. Mol. Cell 83, 4290–4303 (2023).
Wu, C. C., Peterson, A., Zinshteyn, B., Regot, S. & Green, R. Ribosome collisions trigger general stress responses to regulate cell fate. Cell 182, 404–416 (2020).
Sinha, N. K. et al. The ribotoxic stress response drives UV-mediated cell death. Cell 187, 3652–3670 e3640 (2024).
Johnson, J. L. et al. An atlas of substrate specificities for the human serine/threonine kinome. Nature 613, 759–766 (2023).
Chen, J., Waltenspiel, B., Warren, W. D. & Wagner, E. J. Functional analysis of the integrator subunit 12 identifies a microdomain that mediates activation of the Drosophila Integrator complex. J. Biol. Chem. 288, 4867–4877 (2013).
Wang, Z. et al. Coordinated regulation of RNA polymerase II pausing and elongation progression by PAF1. Sci. Adv. 8, eabm5504 (2022).
van den Heuvel, D. et al. A CSB–PAF1C axis restores processive transcription elongation after DNA damage repair. Nat. Commun. 12, 1342 (2021).
Tiwari, V., Kulikowicz, T., Wilson, D. M. III & Bohr, V. A. LEO1 is a partner for Cockayne syndrome protein B (CSB) in response to transcription-blocking DNA damage. Nucleic Acids Res. 49, 6331–6346 (2021).
Sabath, K. et al. INTS10–INTS13–INTS14 form a functional module of Integrator that binds nucleic acids and the cleavage module. Nat. Commun. 11, 3422 (2020).
Sabath, K. et al. Basis of gene-specific transcription regulation by the Integrator complex. Mol. Cell 84, 2525–2541 (2024).
Razew, M., Fraudeau, A., Pfleiderer, M. M., Linares, R. & Galej, W. P. Structural basis of the Integrator complex assembly and association with transcription factors. Mol. Cell 84, 2542–2552 (2024).
van der Weegen, Y. et al. ELOF1 is a transcription-coupled DNA repair factor that directs RNA polymerase II ubiquitylation. Nat. Cell Biol. 23, 595–607 (2021).
Geijer, M. E. et al. Elongation factor ELOF1 drives transcription-coupled repair and prevents genome instability. Nat. Cell Biol. 23, 608–619 (2021).
Hu, J., Adebali, O., Adar, S. & Sancar, A. Dynamic maps of UV damage formation and repair for the human genome. Proc. Natl Acad. Sci. USA 114, 6758–6763 (2017).
Gonzalo-Hansen, C. et al. Differential processing of RNA polymerase II at DNA damage correlates with transcription-coupled repair syndrome severity. Nucleic Acids Res. 52, 9596–9612 (2024).
van Sluis, M. et al. Transcription-coupled DNA–protein crosslink repair by CSB and CRL4CSA-mediated degradation. Nat. Cell Biol. 26, 770–783 (2024).
Steurer, B. et al. DNA damage-induced transcription stress triggers the genome-wide degradation of promoter-bound Pol II. Nat. Commun. 13, 3624 (2022).
Van der Meer, P. J. et al. Hierarchical mechanisms control the clearance of DNA lesion-stalled RNA polymerase II. Nat. Commun. 17, 1647 (2026).
Zhu, Y. et al. Genome-wide mapping of protein–DNA damage interaction by PADD-seq. Nucleic Acids Res. 51, e32 (2023).
Orlando, D. A. et al. Quantitative ChIP-Seq normalization reveals global modulation of the epigenome. Cell Rep. 9, 1163–1170 (2014).
Lavigne, M. D., Konstantopoulos, D., Ntakou-Zamplara, K. Z., Liakos, A. & Fousteri, M. Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate. Nat. Commun. 8, 2076 (2017).
Stein, C. B. et al. Integrator endonuclease drives promoter-proximal termination at all RNA polymerase II-transcribed loci. Mol. Cell 82, 4232–4245 (2022).
Hu, S. et al. INTAC endonuclease and phosphatase modules differentially regulate transcription by RNA polymerase II. Mol. Cell 83, 1588–1604 (2023).
Oka, Y., Nakazawa, Y., Shimada, M. & Ogi, T. Endogenous aldehyde-induced DNA–protein crosslinks are resolved by transcription-coupled repair. Nat. Cell Biol. 26, 784–796 (2024).
Carnie, C. J. et al. Transcription-coupled repair of DNA–protein cross-links depends on CSA and CSB. Nat. Cell Biol. 26, 797–810 (2024).
Suryo Rahmanto, A. et al. K6-linked ubiquitylation marks formaldehyde-induced RNA–protein crosslinks for resolution. Mol. Cell 83, 4272–4289 (2023).
Trendel, J. et al. The human proteome with direct physical access to DNA. Cell 188, 4424–4440 (2025).
Marteijn, J. A., Lans, H., Vermeulen, W. & Hoeijmakers, J. H. Understanding nucleotide excision repair and its roles in cancer and ageing. Nat. Rev. Mol. Cell Biol. 15, 465–481 (2014).
Boeing, S. et al. Multiomic analysis of the UV-induced DNA damage response. Cell Rep. 15, 1597–1610 (2016).
You, Z. & Bailis, J. M. DNA damage and decisions: CtIP coordinates DNA repair and cell cycle checkpoints. Trends Cell Biol. 20, 402–409 (2010).
Matsuoka, S. et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316, 1160–1166 (2007).
Hanasoge, S. & Ljungman, M. H2AX phosphorylation after UV irradiation is triggered by DNA repair intermediates and is mediated by the ATR kinase. Carcinogenesis 28, 2298–2304 (2007).
Ciccia, A. & Elledge, S. J. The DNA damage response: making it safe to play with knives. Mol. Cell 40, 179–204 (2010).
Cordes, J., Zhao, S., Engel, C. M. & Stingele, J. Cellular responses to RNA damage. Cell 188, 885–900 (2025).
Borisova, M. E. et al. p38–MK2 signaling axis regulates RNA metabolism after UV-light-induced DNA damage. Nat. Commun. 9, 1017 (2018).
Troelstra, C. et al. ERCC6, a member of a subfamily of putative helicases, is involved in Cockayne’s syndrome and preferential repair of active genes. Cell 71, 939–953 (1992).
Lans, H., Hoeijmakers, J. H. J., Vermeulen, W. & Marteijn, J. A. The DNA damage response to transcription stress. Nat. Rev. Mol. Cell Biol. 20, 766–784 (2019).
Nguyen, V. T., Kiss, T., Michels, A. A. & Bensaude, O. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature 414, 322–325 (2001).
Yang, Z., Zhu, Q., Luo, K. & Zhou, Q. The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature 414, 317–322 (2001).
Studniarek, C. et al. The 7SK/P-TEFb snRNP controls ultraviolet radiation-induced transcriptional reprogramming. Cell Rep. 35, 108965 (2021).
Bugai, A. et al. P-TEFb activation by RBM7 shapes a pro-survival transcriptional response to genotoxic stress. Mol Cell 74, 254–267 (2019).
Sabatella, M. et al. Repair protein persistence at DNA lesions characterizes XPF defect with Cockayne syndrome features. Nucleic Acids Res. 46, 9563–9577 (2018).
Hamperl, S. & Cimprich, K. A. Conflict resolution in the genome: how transcription and replication make it work. Cell 167, 1455–1467 (2016).
Tufegdzic Vidakovic, A. et al. Analysis of RNA polymerase II ubiquitylation and proteasomal degradation. Methods 159-160, 146–156 (2019).
Gregersen, L. H., Mitter, R. & Svejstrup, J. Q. Using TTchem-seq for profiling nascent transcription and measuring transcript elongation. Nat. Protoc. 15, 604–627 (2020).
Acknowledgements
We thank L. Zhang, J. Wang, W. Deng, Q. Zhao, C. Xu, L. Shen, J. Jin and the core facility of the Life Sciences Institute for helpful suggestions, discussions and technical assistance. This work was supported in part by Zhejiang Provincial Natural Science Foundation of China (LRG25C060001), National Natural Science Foundation of China (32541027, 32570646, 32370591, 32271343, 32070632 an 92053114), National Key R&D Program of China (2022YFA1303000), Fundamental Research Funds for the Central Universities (226-2025-00028), Innovative Research Team of High-level Local University in Shanghai (to J.H.) and Medical Science Data Center of Fudan University.
Author information
Authors and Affiliations
Contributions
Z.L., J.H. and H.L. conceptualized and design the study. H.L., J.H., Z.L., R.L., M.Y. and Y.H. developed the methodology. Z.L., M.Y., Y.H., J.Y., Q.Z., Y.S., W.Z. and C.L. acquired the data. H.L., J.H., Z.L., R.L., M.Y., Y.H., J.Y., Q.Z., Y.S. and C.L. performed data analysis. H.F., Y.-X.X., H.J., D.F., B.Y., Y.L., J.X., L.L., J.H., F.X.C. and L.Z. provided valuable discussion. Z.L., J.H. and H.L. supervised the project and wrote the manuscript. All authors discussed the results and commented on the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Structural & Molecular Biology thanks Julian Stingele and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available. Primary Handling Editor: Dimitris Typas, in collaboration with the Nature Structural & Molecular Biology team.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Characterization of INTS12 phosphorylation.
a, Lysates from HeLa cells that were either untreated or treated with UV (20 J/m2, 20 min recovery), 4-NQO (5 µM, 1 h), MNNG (100 µM, 1 h), MMS (10 mM, 30 min), Anisomycin (20 µM, 1 h), Cycloheximide (100 µg/mL, 1 h) or b, HU (4 mM, 4 h), Bleomycine (10 ug/mL, 1 h), IR (10 Gy, 30 min recovery), Calicheamicin (100 nM, 1 h) as shown in b were separated on Phos-tag SDS-PAGE and immunoblotted with the indicated antibodies. c, HeLa cells expressing the indicated Integrator complex subunit were left untreated or treated with 4-NQO (5 µM, 1 h) and then analyzed as in a. d, Lysates from HeLa cells that were either untreated or treated with 4-NQO (1 µM, 1 h) and recover for the indicated time were analyzed as in a. e, Control or ZAK KO cells were untreated or treated with UV (20 J/m2, 20 min recovery) and then analyzed as in a. f, HeLa cells expressing the indicated Flag-tagged FL or truncated INTS12 proteins were untreated or treated with 4-NQO and then analyzed as in a. g, Mass spectrum of representative INTS12 peptide containing the indicated phosphorylated residue, with both b-ions and y-ions shown in green and yellow, respectively. h, HeLa cells expressing the indicated Flag-tagged mutant INTS12 proteins were untreated or treated with UV and then analyzed as in a. i, Sequence alignments of various INTS12 orthologues in different vertebrates. Green color, Serine (S)/Threonine (T) residues. Conserved phosphorylation residues are highlighted by the red boxes. j, INTS12 protein levels in control, INTS12 KO, and INTS12 KO cells reconstituted with stably expressed WT or 3 A INTS12-Flag were analyzed by WB. k, HeLa cells were depleted of INTS12 (INTS12 KO) and reconstituted with stably expressed WT or 3 A INTS12-Flag. Lysates from cells that were either untreated or treated with 4-NQO were analyzed as in a. All Western blots are representative of three independent experiments.
Extended Data Fig. 2 The role of INTS12 in transcriptional regulation and Integrator complex formation.
a, The levels of INTS1 in control, INTS12 KO, and INTS12 KO cells reconstituted with stably expressed WT or 3 A INTS12-Flag were analyzed by WB. b, Lysates from control or INTS12 KO cells that were treated with CHX for the indicated time were analyzed by WB. c, d, Gradient centrifugation using nuclear extracts from control or INTS12 KO cells (c) or INTS12 KO cells reconstituted with stably expressed WT or 3 A INTS12 (d). The fractionated samples were analyzed using SDS-PAGE followed by WB. e, Schematic illustrating the preDRB-nRNA-seq. Cells released from DRB pretreatment were labeled with 4-SU at the indicated times. f, Heatmaps of preDRB-nRNA-seq data from the TSS into the first 60 kb of active genes larger than 60 kb in control and INTS12 KO cells, followed by the indicated times. g, Metaplots showing the average level of nascent transcription of genes defined in f in control or INTS12 KO cells. Wavefront positions are defined as the distance from the TSS where the reads density drops below an arbitrary threshold (dashed line). All Western blots are representative of three independent experiments.
Extended Data Fig. 3 INTS12 contributes to Integrator recruitment to CSB.
a, Venn diagram showing the number of proteins identified by MS from the INTS12-WT or 3 A interactome. b, Gene Ontology analysis of the MS-identified proteins that specifically interacted with INTS12-WT after UV irradiation. c, INTS12 KO cells reconstituted with stably expressed WT or 3 A INTS12-Flag were untreated or treated with 4-NQO. Chromatin fractions (Input) and anti-Flag immunoprecipitates (IPs) were analyzed by WB. d, Purified recombinant CSB and INTS12 proteins were analyzed by SDS-PAGE and visualized by Coomassie blue staining. e, Control or CSB KO cells expressing INTS12-Flag were either untreated or treated with UV as indicated and then analyzed as in c. f, g, Control or INTS12 KO cells expressing Flag-PAF1 or not (-) were untreated (g) or treated with UV as indicated (f) and then analyzed as in c. h–j, Control or INTS12 KO cells expressing INTS3-Flag (h), INTS5-Flag (i), INTS10-Flag (j) or not (-) were untreated or treated with UV as indicated and then analyzed as in c. k, l, Control or INTS12 KO expressing INTS5-Flag (k) or not (l) were treated with DMSO or 4-NQO (5 µM, 1 h) and subject to PLA using the indicated antibodies. Right: quantification of PLA foci per nucleus (n = 141). P < 0.0001. m, HeLa cells expressing INTS10-Flag together with either INTS3-Strep or INTS3 (∆CMBM)-Strep were lysed to prepare for the whole cell extracts (WCEs). WCEs (Input) and anti-strep immunoprecipitates (IPs) were analyzed by WB. n, HeLa cells expressing INTS3-Strep or INTS3 (∆CMBM)-Strep were either untreated or treated with UV as indicated and then analyzed as in c. For k and l, box plots show the minimum, quartiles and maximum. Scale bar, 10 μm. Statistical analysis was performed using two-tailed unpaired t-tests. All Western blots are representative of three independent experiments.
Extended Data Fig. 4 INTS12 and its phosphorylation are required for efficient transcriptional recovery following UV irradiation.
a, Clonogenic survival of control, INTS12 KO and CSB KO cells treated with indicated doses of 4-NQO. Graphs represent the mean ± s.d. from n = 3 repeated experiments and were normalized to the untreated colony number, which was set at 100%. b, c, Cell survival of control and INTS12 KO cells treated with indicated doses of IR (b) or Calicheamicin (c). Graphs represent the mean ± s.d. from n = 3 repeated experiments and were normalized to the untreated cell number, which was set at 100%. d, e, INTS12 KO cells reconstituted with either INTS12-WT or INTS12-3A were treated with indicated doses of UV (d) or 4-NQO (e) and subjected to clonogenic survival assays. Graphs represent the mean ± s.d. from n = 3 repeated experiments and were normalized to the untreated colony number, which was set at 100%. f, Quantification of fluorescence intensity per cell for data shown in Fig. 3b and are representative of three independent experiment (n = 238). Red lines indicate the mean intensity in each group. g, Transcription recovery in INTS12 KO cells reconstituted with either INTS12-WT or INTS12-3A following UV irradiation was measured by 5-EU labeling of newly synthesized RNA. Right: Quantification of fluorescence intensity per cell and are representative of three independent experiment (n = 216). Red lines indicate the mean intensity in each group. Scale bar, 50 μm. h, Transcription recovery in control, ZAK KO and ZAKi-treated (Nilotinib, 1 µM, pre-1h) cells following UV irradiation was measured by 5-EU labeling of newly synthesized RNA. Bottom: Quantification of fluorescence intensity per cell and are representative of three independent experiment (n = 242). Red lines indicate the mean intensity in each group. Scale bar, 20 μm. i, Metaplots showing the average TT-seq signal levels of genes between 10-25 kb, 25-50 kb, and 50-100 kb in control and INTS12 KO cells after mock or UV treatment, followed by recovery for the indicated times.
Extended Data Fig. 5 INTS12 and its phosphorylation facilitate DNA repair by TC-NER following UV irradiation.
a, qRT-PCR analysis of the mRNA levels of XPC in the indicated cells. The error bars indicate mean ± s.d. with n = 3 biologically independent samples. b, Unscheduled DNA synthesis in mock or UV-irradiated XPC-deficient cells that were either untreated or treated by ZAKi (1 µM, pre-1h) were analyzed by EdU labeling. Right: Quantification of relative EdU levels per cell (n = 128, 128, 121, 123). Red lines indicate the mean intensity in each group. Scale bar, 50 μm. c, Metaplots of XR-seq signal across gene body regions for nonoverlapping protein-coding genes in DMSO- or ZAKi-treated cells after UV treatment. d, Relative quantification of TCR activity based on the ratio of XR-seq read counts from TSs and NTSs in expressed protein-coding genes (n = 3901, TPM > 5). P < 7.03E-298. e, Metaplots showing the average level of TCR-seq signals from the TSS until the TTS (−2 kb and +2 kb, respectively) in control or INTS12 KO cells after mock or UV treatment, followed by recovery for the indicated times. f, Genome browser tracks showing the strand-specific TCR-seq read distribution across the representative gene in mock- or UV-irradiated control and INTS12-KO cells. g, Time course analysis of the recovery index (RI) in control and INTS12-KO cells following UV irradiation to estimate TC-NER kinetics on a global scale. h, Strand-specificity index (SSI) scatterplots derived from TCR-seq signals of allexpressed genes in control or INTS12 KO cells after mock or UV treatment, followed by recovery for the indicated times. Statistical analysis was performed using two-tailed unpaired t-tests.
Extended Data Fig. 6 INTS12-mediated removal of lesion-stalled Pol II following UV irradiation.
a, Soluble and chromatin fractions from untreated or UV-irradiated control and INTS12 KO cells were analyzed by WB. b, Control or CSA KO cells expressing INTS12-Flag or not (-) were either untreated or treated with UV irradiation (20 J/m2, 1 h recovery). Chromatin fractions (Input) and anti-Flag immunoprecipitates (IPs) were analyzed by WB. c, Lysates from parental or Halo-RPB1 U2OS cells were analyzed by WB. d, FRAP analysis of Halo-RPB1 U2OS cells that were either untreated or treated with UV (8 J/m2, 1 h recovery) or FA (0.3 mM, 1 h). The relative fluorescence intensity (RFI) of Halo-RPB1 was measured every second for 220 s and normalized to pre-bleach fluorescence intensity (set to 1.0). Right: relative immobile fractions of Halo-RPB1, which were calculated by comparing RFI after UV treatment to untreated samples. Data are the mean ± s.e.m. of n = 4 biologically independent samples for the untreated and FA-treated groups, and n = 6 for the UV-treated group. e, Chromatin fractions from control, CSB KO, or INTS12 KO cells treated with THZ and/or UV as indicated were analyzed by WB. f, Control or INTS12 KO cells were either untreated or treated with UV (20 J/m2) followed by CHX (100 µg/mL) treatment. Lysates from cells that were harvested at the indicated time points were analyzed by WB. g, Metaplots of PADD-seq signals around TSSs and TESs for active genes longer than 50 kb under the indicated conditions. Right: quantification of Pol II retention on damage sites by relative change of PADD-seq signals from 0.5 h to 2 h on active genes longer than 20 kb. P < 9.8E-159. h, R-loop levels in mock- or 4-NQO-treated control, INTS12 or CSB KO cells were detected by GFP-dRNH1. Bottom: Quantification of mean nuclear GFP-dRNH1 intensity per cell and are representative of three independent experiment (n = 231, 242, 202, 202, 241, 231). Red lines indicate the mean intensity in each group. Scale bar, 50 μm. Statistical analysis was performed using two-tailed unpaired t-tests. All Western blots are representative of three independent experiments.
Extended Data Fig. 7 INTS12 phosphorylation and the Integrator’s endonuclease activity are required for establishing UV-induced Pol II elongation wave.
a, Heatmaps of Pol II ChIP-Rx signals across gene body regions in control cells after mock or different doses of UV treatment, followed by 1 h recovery. Genes were ranked by decreasing Pol II occupancy under mock treatment conditions. FC, fold change. b, Heatmaps of Pol II ChIP-seq signals across gene body regions in CSB KO cells after mock or UV treatment, followed by recovery for the indicated times. Genes were ranked by decreasing Pol II occupancy under mock treatment conditions. FC, fold change. c, Metaplots of Pol II ChIP-seq signals across gene body regions in CSB KO cells after mock or UV treatment, followed by recovery for the indicated times. d, Schematic illustrating the preDRB-nRNA-seq. Cells released from DRB pretreatment were labeled with 4-SU at the indicated times after recovery from UV irradiation. e, Heatmaps of the Pol II ChIP-Rx signals across gene body regions in INTS12 KO cells reconstituted with stably expressed WT INTS12-Flag after mock treatment or UV treatment, followed by recovery for the indicated times. Genes were ranked by decreasing Pol II occupancy under mock treatment conditions. FC, fold change. f, Metaplots of Pol II ChIP-Rx signals across gene body regions in INTS12-WT cells after mock or UV treatment, followed by recovery for the indicated times. g, Heatmaps of the Pol II ChIP-Rx signals across gene body regions in INTS12 KO cells reconstituted with stably expressed WT INTS12-Flag after mock treatment or UV treatment, followed by recovery for the indicated times. Genes were ranked by decreasing Pol II occupancy under mock treatment conditions. FC, fold change. h, Metaplots of Pol II ChIP-Rx signals across gene body regions in INTS12-3A cells after mock or UV treatment, followed by recovery for the indicated times. i, Cumulative distribution of PSI in INTS12 KO cells reconstituted with stably expressed WT or 3 A INTS12-Flag. j, Lysates from parental or INTS11-dTAG DLD1 cells treated with indicated chemicals were analyzed by WB. k, l, Heatmaps of Pol II ChIP-Rx signals across gene body regions in DMSO (k) or dTAG (l) treated INTS11-dTAG DLD1 cells after mock or UV treatment, followed by recovery for the indicated times. Genes were ranked by decreasing Pol II occupancy under mock treatment conditions. FC, fold change. m, n, Metaplots of Pol II ChIP-Rx signals across gene body regions in DMSO (m) or dTAG (n) treated INTS11-dTAG DLD1 cells after mock or UV treatment, followed by recovery for the indicated times.
Extended Data Fig. 8 INTS12-coordinated Pol II removal is dispensable for TC-DPC repair.
a, INTS12 KO cells reconstituted with stably expressed WT or 3 A INTS12-Flag were either untreated or treated with FA (1 mM, 1 h). Chromatin fractions (Input) and anti-Flag immunoprecipitates (IPs) were analyzed by WB. b, Control or INTS12 KO cells expressing INTS10-Flag or not (-) were untreated or treated with FA (1 mM, 1 h) and analyzed as in a. c, HeLa cells were untreated or treated with Camptothecin (CPT, 1 µM, 30 min, left) or 5-Aza-2’-deoxycytidine (5-aza-dc, 100 µM, 30 min, right) as indicated. Lysates were separated on Phos-tag SDS-PAGE and immunoblotted with the indicated antibodies. d, Lysates from HeLa cells that were untreated or treated with 4ST (4 d) and UVA (recover 30 min) were analyzed as in c. e, Schematic illustrating the potential role of INTS12 and its coordinated Pol II removal in TC-DPC repair. f, Box plots showing the DPC-seq coverage per gene in control, INTS12 KO, or CSB KO cells with or without 4 h recovery after FA treatment (n = 9288). Control, P < 2.2E-16; INTS12 KO, P < 2.2E-16; CSB KO, P = 1.7E-15. g, Heatmaps of DPC-seq data in control, INTS12 KO, or CSB KO cells after FA treatment followed by recovery for the indicated times. Genes were grouped into non, low, medium and high transcriptional activity gene sets as determined by TT-seq. h, i, Metaplots showing the average DPC-seq signal levels of all expressed (h) or non-expressed (i) genes in control, INTS12 KO, or CSB KO cells with or without 4 h recovery after FA treatment. j, Genome browser tracks showing the DPC-seq read distribution across the representative inactive gene in control, INTS12 KO, or CSB KO cells after FA treatment followed by recovery for the indicated times. For f, box plots show the minimum, quartiles and maximum. Statistical analysis was performed using two-tailed unpaired t-tests. All Western blots are representative of three independent experiments.
Supplementary information
Supplementary Information
Supplementary Tables 1 and 2.
Supplementary Tables
Supplementary Table 1: Detailed information regarding the plasmids and oligonucleotides used in the study. Supplementary Table 2: Light microscopy reporting table.
Source data
Source Data Figs. 1–5 and Extended Data Figs. 1–3 and 6–8
Unprocessed western blots.
Source Data Figs. 2–5 and Extended Data Figs. 3–6
Statistical source data.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, Z., Li, R., Yang, M. et al. Integrator subunit INTS12 links ribotoxic stress to transcription-coupled nucleotide excision repair. Nat Struct Mol Biol (2026). https://doi.org/10.1038/s41594-026-01766-y
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41594-026-01766-y